Cargando…

Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction

BACKGROUND: Excessive immune‐mediated inflammatory reactions play a deleterious role in postinfarction ventricular remodeling. Interleukin‐37 (IL‐37) emerges as an inhibitor of both innate and adaptive immunity. However, the exact role of IL‐37 and IL‐37 plus troponin I (TnI)–treated dendritic cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ruirui, Sun, Haitao, Yu, Kunwu, Zhong, Yucheng, Shi, Huairui, Wei, Yuzhen, Su, Xin, Xu, Wenbin, Luo, Quan, Zhang, Fangyuan, Zhu, Zhengfeng, Meng, Kai, Zhao, Xiaoqi, Liu, Yuzhou, Mao, Yi, Cheng, Peng, Mao, Xiaobo, Zeng, Qiutang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210436/ https://www.ncbi.nlm.nih.gov/pubmed/27919929 http://dx.doi.org/10.1161/JAHA.116.004406

Ejemplares similares

Role of IL-37- and IL-37-Treated Dendritic Cells in Acute Coronary Syndrome
por: Zhu, Ruirui, et al.
Publicado: (2021)

IL-37 Plays a Beneficial Role in Patients with Acute Coronary Syndrome
por: Mao, Xiaobo, et al.
Publicado: (2019)

Lanatoside C Promotes Foam Cell Formation and Atherosclerosis
por: Shi, Huairui, et al.
Publicado: (2016)

Interleukin-27 Ameliorates Atherosclerosis in ApoE(−/−) Mice through Regulatory T Cell Augmentation and Dendritic Cell Tolerance
por: Xu, Wenbin, et al.
Publicado: (2022)

Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019)

Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice
por: Ji, Qingwei, et al.
Publicado: (2017)

Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP
por: Zhao, Xiaoqi, et al.
Publicado: (2015)

Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals
por: Zhu, Ruirui, et al.
Publicado: (2015)

The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis
por: Omenesa Bello, Ramatu, et al.
Publicado: (2018)

Interleukin-37 as fundamental inhibitor of innate immunity
por: Bufler, P
Publicado: (2011)

The emerging role of interleukin‐37 in cardiovascular diseases
por: Zhuang, Xinyu, et al.
Publicado: (2017)

The Role of Interleukin-37 in the Pathogenesis of Allergic Diseases
por: Shilovskiy, I. P., et al.
Publicado: (2019)

Modulation of Liver Inflammation and Fibrosis by Interleukin-37
por: Mountford, Steffeni, et al.
Publicado: (2021)

Interleukin-37 is involved in the immunopathogenesis of infectious mononucleosis
por: Zhao, Mingsheng, et al.
Publicado: (2023)

Correlation Between Level of Interleukin-37 and Rheumatoid Arthritis Progression
por: Zhu, Jifeng, et al.
Publicado: (2021)

Elevated levels of interleukin‐35 and interleukin‐37 in adult patients with obstructive sleep apnea
por: Chen, Bi, et al.
Publicado: (2021)

Interleukin 37 is a fundamental inhibitor of innate immunity
por: Nold, Marcel F, et al.
Publicado: (2010)

Reviews of Interleukin-37: Functions, Receptors, and Roles in Diseases
por: Jia, Hailin, et al.
Publicado: (2018)

The potential of interleukin-37 as an effective therapeutic agent in asthma
por: Zhang, Lina, et al.
Publicado: (2017)

Interleukin 37 (IL-37) Reduces High Glucose-Induced Inflammation, Oxidative Stress, and Apoptosis of Podocytes by Inhibiting the STAT3–Cyclophilin A (CypA) Signaling Pathway
por: Zhang, Xiaobo, et al.
Publicado: (2020)

Interleukin-37 (IL-37) Suppresses Pertussis Toxin-Induced Inflammatory Myopathy in a Rat Model
por: Yan, Peng, et al.
Publicado: (2018)

Interleukin-37 protects against acinar cell pyroptosis in acute pancreatitis
por: Ma, Nan, et al.
Publicado: (2022)

Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence
por: Zhang, Ying, et al.
Publicado: (2021)

GARP and GARP-Treated tDC Prevented the Formation of Atherosclerotic Plaques in ApoE(−/-) Mice
por: Cai, Yifan, et al.
Publicado: (2021)

Interleukin‐37 inhibits osteoclastogenesis and alleviates inflammatory bone destruction
por: Tang, Ruohui, et al.
Publicado: (2018)

Interleukin 37 promotes angiogenesis through TGF-β signaling
por: Zhao, Mengmeng, et al.
Publicado: (2017)

Interleukin-37 Inhibits Colon Carcinogensis During Chronic Colitis
por: Mountford, Steffeni, et al.
Publicado: (2019)

Analysis of Serum Interleukin-37 Level and Prognosis in Patients with ACS
por: Liu, Canjun, et al.
Publicado: (2021)

Biology of interleukin-37 and its role in autoimmune diseases (Review)
por: Zeng, Huiqiong, et al.
Publicado: (2022)

Interleukin-37: associations of plasma levels and genetic variants in gout
por: Andres Cerezo, Lucie, et al.
Publicado: (2023)

Circulating interleukin-37 declines with aging in healthy humans: relations to healthspan indicators and IL37 gene SNPs
por: Brunt, Vienna E., et al.
Publicado: (2022)

Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still’s Disease
por: Nam, Seoung Wan, et al.
Publicado: (2021)

Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
por: Chen, Bingni, et al.
Publicado: (2015)

Interleukin-37 exacerbates experimental colitis in an intestinal microbiome-dependent fashion
por: Cong, Junxiao, et al.
Publicado: (2022)

Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
por: Zeng, Qingxiang, et al.
Publicado: (2023)

IL-37 Expression in Patients with Abdominal Aortic Aneurysm and Its Role in the Necroptosis of Vascular Smooth Muscle Cells
por: Ding, Yan, et al.
Publicado: (2022)

Exogenous Interleukin-37 Alleviates Hepatitis with Reduced Dendritic Cells and Induced Regulatory T Cells in Acute Murine Cytomegalovirus Infection
por: Ruan, Yufei, et al.
Publicado: (2023)

Thymic Stromal Lymphopoietin Attenuates the Development of Atherosclerosis in ApoE(−/−) Mice
por: Yu, Kunwu, et al.
Publicado: (2013)

Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity
por: Chi, Huihui, et al.
Publicado: (2018)

Entecavir downregulates interleukin-37 in patients with chronic active hepatitis B infection
por: Meng, Jiang-Ping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_12m5ihdh5toim3baphkjnvshtu